Key result
This review summarizes novel biomarkers and advanced biosensing technologies for the rapid diagnosis of Japanese Encephalitis Virus to enable future point-of-care screening.
Why the study?
Proactive research into advanced biosensor technology and biomarkers is needed to develop rapid, sensitive, and specific diagnostic screening methods to manage Japanese Encephalitis outbreaks.
This review summarizes current research on biomarkers and biosensors for the rapid diagnosis of Japanese Encephalitis Virus to aid in future point-of-care diagnostic development.
Advanced biosensor technology research is imperative for the management of infectious disease outbreaks such as Japanese Encephalitis (JE), a zoonotic disease caused by the flavivirus JE virus (JEV) which is transmitted to humans (dead-end hosts) from the amplification host, pigs, via mosquitoes. To avoid future pandemic scenarios, proactive research rather than responsive research in the field of diagnostics is a requirement for development of rapid, sensitive and specific screening detection methods. In this mini-review, we have critically compared and evaluated the different types of biomarkers (antigen, antibody, nucleic acid) identified for JEV diagnostics and their specific roles in the manifestation of the infection which may be potentially used for therapeutics and drug development as no treatment is available for JE. Furthermore, different biosensors developed for the detection of JEV biomarkers have been discussed in detail to give an overview of the working principles (electrochemical, optical, etc.), fabrication components (signal amplifier, bioreceptor, etc.), detection limits and response times. This review provides a compact compiled base on available JEV diagnostic research work being currently carried out along with their limitations, future prospective, and major challenges faced. This will enable future development of rapid point-of-care diagnostic screening methods for JEV infection management, which may help reduce number of fatalities.
No takes yet. Share an insight, caveat, or question.
Roberts et al. (2022) conducted a review in Japanese Encephalitis Virus (JEV) infection. Biosensors and biomarkers for JEV diagnostics was evaluated. This review summarizes novel biomarkers and advanced biosensing technologies for the rapid diagnosis of Japanese Encephalitis Virus to enable future point-of-care screening.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: